<DOC>
	<DOCNO>NCT00166543</DOCNO>
	<brief_summary>This study do find safe TAS-108 well TAS-108 work recurrent recurrent inoperable breast cancer .</brief_summary>
	<brief_title>Three Doses TAS-108 Treat Recurrent Recurrent Inoperable Breast Cancer</brief_title>
	<detailed_description>The objective study investigate efficacy safety TAS-108 administer postmenopausal patient locally advance locally recurrent inoperable progressive metastatic breast carcinoma previously respond one two standard endocrine therapy , without one prior chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Postmenopausal females Histologically cytologically confirm diagnosis breast carcinoma Locally advance locally recurrent inoperable metastatic breast carcinoma document disease progression Has laboratory documentation positive estrogen receptor ( ER ) and/or progesterone receptor ( PgR ) status , respond standard first second line hormonal antitumor therapy give Has receive whose disease progress one two prior systemic hormonal antitumor therapy Performance status great equal 2 Zubrod scale Predicted life expectancy great equal 12 week Must give write informed consent Measurable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion Absolute granulocyte count great 1,500/meqL , platelet count great 75,000/meqL , hemoglobin great 10 g/dL Adequate liver renal function define bilirubin less 1.5 time upper limit normal creatinine le 1.5 time upper limit normal Transaminases must less 2.5 time upper limit normal except patient liver metastasis may transaminases less 5 time upper limit normal . The patient recover previous anticancer treatment related toxicity least Grade 1 . All previous investigational drug must stop least four week commencement treatment TAS108 .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>locally advanced breast carcinoma</keyword>
	<keyword>locally recurrent inoperable breast carcinoma</keyword>
	<keyword>progressive metastatic breast carcinoma</keyword>
</DOC>